Catalyst Wire Dossier Catalyst Wire Dossier

esmirtazapine

esmirtazapine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for esmirtazapine, covering 2014-07-10 to 2014-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708) [Phase 3]

See pricing